Vestal Point Capital’s Monte Rosa Therapeutics GLUE Stock Holding History

Vestal Point Capital’s Portfolio GLUE Stock Details GLUE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$5.93M	Buy
2025 Q1	–	Sell
2024 Q4	$2.95M	Sell
2024 Q3	$4.93M	Buy
2024 Q2	$3.33M	Buy